Lv11
60 积分 2025-01-15 加入
Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017–2024)
6个月前
已完结
A novel amino-pyrimidine inhibitor suppresses tumor growth via microtubule destabilization and Bmi-1 down-regulation
9个月前
已完结
皖公网安备34019202002308
